Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...

Under the terms of the collaboration, Iktos will apply its generative AI and AI-orchestrated robotics platform to design, synthesize, and optimize small molecules for multiple undisclosed targets.

Schrödinger (SDGR) and Revvity (RVTY) on Friday announced collaborations with Eli Lilly (LLY) to integrate their respective ...

The team brings a strong balance of scientific and commercial expertise, has built a unique data foundation with a ...

MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...

Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...

For decades, the process of drug discovery has been a prolonged, costly, and unpredictable endeavor — an effort that ...

The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...

Explore how Insilico collaborates with Servier to advance AI-driven drug discovery in oncology for unmet medical needs.

The integration of TuneLab into Schrodinger’s cloud-based LiveDesign platform will provide biotech companies with direct ...